Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Cytochroma
Exited company

Cytochroma Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn More
Investor
Ela Borenstein

Vice President

View profile
About the company

Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).